The U.S. Breast Cancer Liquid Biopsy Market is projected to grow from USD 0.39 Billion in 2025 to USD 0.84 Billion by 2035, while Europe is expected to expand from USD 0.35 Billion to USD 0.78 Billion, driven by increasing companion diagnostic adoption, expanding precision oncology programs, and growing utilization of ctDNA testing.
The U.S. Breast Cancer Liquid Biopsy Market is projected to grow from USD 0.39 Billion in 2025 to USD 0.84 Billion by 2035, while Europe is expected to expand from USD 0.35 Billion to USD 0.78 Billion, driven by increasing companion diagnostic adoption, expanding precision oncology programs, and growing utilization of ctDNA testing.